Conditional survival predictions after nephrectomy for renal cell carcinoma.

Archive ouverte

Karakiewicz, Pierre, I. | Suardi, Nazareno | Capitanio, Umberto | Isbarn, Hendrik | Jeldres, Claudio | Perrotte, Paul | Sun, Maxine | Ficarra, Vincenzo | Zigeuner, Richard | Tostain, Jacques | Mejean, Arnaud | Cindolo, Luca | Pantuck, Allan, J. | Belldegrun, Arie, S. | Zini, Laurent | de La Taille, Alexandre | Chautard, Denis | Descotes, Jean-Luc | Shariat, Shahrokh, F. | Valeri, Antoine | Mulders, Peter, F. | Lang, Hervé | Lechevallier, Eric | Patard, Jean-Jacques

Edité par CCSD ; Elsevier -

International audience. PURPOSE: Conditional survival implies that on average long-term cancer survivors have a better prognosis than do newly diagnosed individuals. We explored the effect of conditional survival in renal cell carcinoma. MATERIALS AND METHODS: We studied 3,560 patients with renal cell carcinoma of all stages treated with nephrectomy. We applied conditional survival methodology to a previously reported posttreatment nomogram predicting survival after nephrectomy for patients with renal cell carcinoma stage I to IV. We used the same predictor variables that were integrated in the original multivariable Cox regression models, namely TNM stage, Fuhrman grade, tumor size and symptom classification. To validate the conditional survival nomogram we used an independent cohort of 3,560 patients from 15 institutions. RESULTS: The 5-year survival of patients immediately after nephrectomy was 74.2%, which increased to 80.4%, 85.1%, 90.6% and 89.6% at 1, 2, 5 and 10 years after nephrectomy, respectively. The predicted probabilities varied by as much as 50% when, for example, predictions of renal cell carcinoma specific mortality at 10 years were made after nephrectomy vs 5 years later. Within the external validation cohort the accuracy of the conditional nomogram was 89.5%, 90.5%, 88.5% and 86.7% at 1, 2, 5 and 10 years after nephrectomy. CONCLUSIONS: We developed (2,530) and externally validated (3,560) a conditional nomogram for predicting renal cell carcinoma specific mortality that allows consideration of the length of survivorship. Our tool provides the most realistic prognosis estimates with high accuracy.

Consulter en ligne

Suggestions

Du même auteur

Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy.

Archive ouverte | Karakiewicz, Pierre, I. | CCSD

International audience. OBJECTIVE: Based on combined data for 4880 patients, 2 previous studies reported that advanced age is a predictor of increased renal cell carcinoma-specific mortality (RCC-SM). We explored th...

Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?

Archive ouverte | Jeldres, Claudio | CCSD

International audience. PURPOSE: Fuhrman grade represents a key determinant of the natural history of small renal masses that represent renal cell carcinoma. We tested whether renal mass biopsy prediction of Fuhrman...

Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.

Archive ouverte | Capitanio, Umberto | CCSD

International audience. OBJECTIVE: To quantify the survival disadvantage related to the presence of exclusive nodal metastases (eNM) in patients with otherwise non-metastatic (M0) renal cell carcinoma (RCC). PATIENT...

Chargement des enrichissements...